NRF2-regulated cell cycle arrest at early stage of oxidative stress response mechanism

PLoS One. 2018 Nov 28;13(11):e0207949. doi: 10.1371/journal.pone.0207949. eCollection 2018.

Abstract

Oxidative stress results in activation of several signal transduction pathways controlled by the PERK-substrate NRF2 (nuclear factor erythroid 2-related factor 2); meanwhile the ongoing cell division cycle has to be blocked. It has been recently shown that Cyclin D1 got immediately down-regulated via PERK pathway in response to oxidative stress leading to cell cycle arrest. However, the effect of NRF2 on cell cycle regulation has not been explored yet. We aimed to reveal a crosstalk between PERK-substrate NRF2 and the key elements of cell cycle regulatory network upon oxidative stress using molecular biological techniques- Although Cyclin D1 level remained constant, its activity was blocked by various stoichiometric inhibitors (such as p15, p21 and p27) even at low level of oxidative stress. The activity of these CDK inhibitors completely disappeared, when the addition of oxidative agent was combined with silencing of either PERK or NRF2.This further confirms the important role of NRF2 in blocking Cyclin D1 with stoichiometric inhibitors at early stage of oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle Checkpoints / physiology*
  • Cyclin D1 / metabolism
  • HEK293 Cells
  • Humans
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidative Stress / physiology*
  • eIF-2 Kinase / metabolism

Substances

  • CCND1 protein, human
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Cyclin D1
  • EIF2AK3 protein, human
  • eIF-2 Kinase

Grants and funding

Orsolya Kapuy was supported by the Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, Budapest and by the New National Excellence Program of the Ministry of Human Capacities ÚNKP-17-4-III-SE-75. Orsolya Kapuy and Gábor Bánhegyi were supported by the National Research, Development and Innovation Office (K 112696 and 124813). Margita Márton was supported by the New National Excellence Program of the Ministry of Human Capacities ÚNKP-17-3-I-SE-30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.